Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Public Access To FDA Compliance, Enforcement Data Would Grow Under New Proposals

This article was originally published in The Gray Sheet

Executive Summary

FDA’s Transparency Task Force is floating ideas for making the agency’s compliance and enforcement data more accessible to the public.

You may also be interested in...



Regulatory News In Brief

FDA issues final rule on Strategic National Stockpile of devices, drugs and biologics. Commissioner adopts proposals to make compliance data more transparent. More regulatory briefs.

Regulatory News In Brief

FDA enforcement activities available online

Guido Rasi - The Face Of The EMA For A Decade

The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.

 

Topics

UsernamePublicRestriction

Register

MT030622

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel